Thromboembolic and bleeding events in ICU patients with COVID-19: A nationwide, observational study

Lene Russell1, Sarah Weihe2, Emilie Kabel Madsen3

  • 1Department of Intensive Care, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.

Insights

COVID-19 patients in intensive care units (ICUs) frequently experienced thromboembolic and bleeding events. Increased doses of thromboprophylaxis did not appear beneficial for these critically ill patients.

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Hematology

Background:

  • Coronavirus disease 2019 (COVID-19) patients admitted to intensive care units (ICUs) face a heightened risk of thromboembolic complications.
  • Understanding the incidence and predictors of these events is crucial for managing critically ill patients.

Purpose of the Study:

  • To describe the occurrence of thromboembolic and bleeding events in Danish ICU patients with COVID-19 during the initial pandemic waves.
  • To identify factors associated with these events and their impact on 90-day mortality.

Main Methods:

  • A sub-study of the Danish Intensive Care Covid database included all SARS-CoV-2 patients admitted to ICUs between March 2020 and June 2021.
  • Coagulation variables, thromboembolic/bleeding events, and heparin use were registered. Cox regression analyses assessed associations with mortality.

Main Results:

  • Of 1369 patients, 12% experienced thromboembolic events and 23% had bleeding events (6% major bleeding).
  • Mechanical ventilation and elevated D-dimer predicted thrombosis; low platelets and hematological malignancy predicted bleeding.
  • While 76% received increased thromboprophylaxis, thromboembolic events were not linked to mortality, but bleeding events were (HR 1.55).

Conclusions:

  • Thromboembolic and bleeding complications are common in critically ill COVID-19 patients.
  • The data suggest that increased doses of thromboprophylaxis may not confer significant benefits in this population.
Abstract

Related Concept Videos

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
32
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
18
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
19
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
28
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
34
Pulmonary Embolism III: Nursing Management01:27

Pulmonary Embolism III: Nursing Management

A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
27